Sketchy behavior

anonymous

Guest
Tons of reports, from providers, of overly aggressive Ingrezza reps. Especially in LTC. One provider claimed the Ingrezza rep sifted through PI and charts, circling which names to switch from Cogentin to Ingrezza. Going to be a dark day for Neurocrine soon..
 












Tons of reports, from providers, of overly aggressive Ingrezza reps. Especially in LTC. One provider claimed the Ingrezza rep sifted through PI and charts, circling which names to switch from Cogentin to Ingrezza. Going to be a dark day for Neurocrine soon..
What area ? Assuming that person is long gone now
 


















Tons of reports, from providers, of overly aggressive Ingrezza reps. Especially in LTC. One provider claimed the Ingrezza rep sifted through PI and charts, circling which names to switch from Cogentin to Ingrezza. Going to be a dark day for Neurocrine soon..
Yes there is a shit ton of under the table stuff going on. This ain’t sales it’s sketchy BS practices. The whistle blowers are coming out on this. It ain’t gonna be pretty.